Doxorubicin free base

For research use only. Not for therapeutic Use.

  •  $1595/500mg

  • Click HERE to Order
  • CAT Number: I006525
  • CAS Number: 23214-92-8 (free base)
  • Molecular Formula: C27H29NO11
  • Molecular Weight: 543.52
  • Purity: 97%
Inquiry Now

Doxorubicin Free Base(Cat No.:I006525)is a powerful anthracycline antibiotic used as a chemotherapy agent. It works by intercalating into DNA, inhibiting topoisomerase II, and generating free radicals, which cause DNA strand breaks and prevent cell replication. Doxorubicin is widely used in the treatment of various cancers, including breast cancer, lymphoma, and leukemia. Its effectiveness in disrupting DNA synthesis makes it a cornerstone of cancer therapy. However, it is associated with cardiotoxicity, requiring careful monitoring during treatment. Its free base form allows flexibility in drug formulation and research applications.


Catalog Number I006525
CAS Number 23214-92-8 (free base)
Synonyms

ADR; chloridrato de doxorrubicina. Adriamycin; Adriacin; Adriblastina; Adriblastine; Adrimedac; DOXOCELL; Doxolem; Doxorubin; Farmiblastina; Rubex. Abbreviations: ADM; Adria; DOX. Code name: FI106;;(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-meth

Molecular Formula C27H29NO11
Purity 97%
Target Antibody-drug Conjugate/ADC Related
Solubility This product has low solubility in all common solvents.
Storage 0 - 4°C for short term or -20 °C for long term
Related CAS 56420-45-2     25316-40-9     56390-09-1     57918-24-8    
IUPAC Name (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
InChI InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1
InChIKey AOJJSUZBOXZQNB-TZSSRYMLSA-N
SMILES C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O

Request a Quote